the targets and indicators. An oral report on this discussion will be provided at the Board meeting. The 2012/13 targets and indicators are set out in the table below: 2012/13 Targets and Indicators Area Indicator Threshold Weighting Safety Clostridium (C.) difficile meeting the C. 0 1.0 – difficile objective (1) Safety Methicillin-resistant Staphylococcus aureus 0 1.0 (MRSA) bacteraemia meeting the MRSA – objective Patient Maximum time of 18 weeks from point of 90% 1.0 Experience referral to treatment in aggregate admitted – (2) Patient Maximum time of 18 weeks from point of 95% 1.0 Experience referral to treatment in aggregate – (2) Patient Maximum time of 18 weeks from point of 92% 1.0 Experience referral to treatment in aggregate patients – on an incomplete pathway (2) Quality A&E: maximum waiting time of four hours 95% 1.0 from arrival to admission/transfer/discharge (3)
the targets and indicators. An oral report on this discussion will be provided at the Board meeting. The 2012/13 targets and indicators are set out in the table below: 2012/13 Targets and Indicators Area Indicator Threshold Weighting Safety Clostridium (C.) difficile – meeting the C. difficile objective (1) 0 1.0 Safety Methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia – meeting the MRSA objective 0 1.0 Patient Experience Maximum time of 18 weeks from point of referral to treatment in aggregate – admitted (2) 90% 1.0 Patient Experience Maximum time of 18 weeks from point of referral to treatment in aggregate – (2) 95% 1.0 Patient Experience Maximum time of 18 weeks from point of referral to treatment in aggregate – patients on an incomplete pathway (2) 92% 1.0 Quality A&E: maximum waiting time of four hours from arrival to admission/transfer/discharge (3) 95% 1.0
57_BOD_MonitorQ4.docx